The Series A Sprint: Science, Fundraising, and Clinical Ops Collide
The transition from seed to Series A marks one of the most operationally demanding periods for any biotech startup. According to the Biotechnology Innovation Organization (BIO), U.S. biotech venture investment totaled approximately $25 billion in 2024, with Series A and B rounds averaging $45 million and $85 million respectively for clinical-stage companies. To close these rounds, founding teams must simultaneously run ongoing science, conduct investor roadshows, assemble a due diligence data room, and negotiate CRO contracts for the clinical program that the new capital will fund.
For a founding team of three to six scientists and executives, this convergence creates an impossible administrative load. Virtual assistants with experience in biotech or life sciences operations are increasingly stepping in as the operational spine of the Series A sprint.
Due Diligence Data Room Assembly: First Impressions Are Structural
Lead investors and their scientific advisory teams typically conduct due diligence through a secure virtual data room (VDR) on platforms such as Datasite, Intralinks, or Firmex. The quality and organization of this data room is not merely a housekeeping matter—it is a signal about the founding team's operational sophistication.
A well-organized data room includes structured folders for corporate governance documents, IP filings and freedom-to-operate opinions, preclinical data packages, regulatory correspondence, financial models, key personnel CVs and employment agreements, and material contracts. Investors conducting technical reviews expect to find documents where they expect to find them, with version control that makes clear which documents are current.
Assembling and maintaining this data room during a live fundraise is a significant administrative project. A VA can build the initial folder taxonomy, populate existing documents from internal file systems, track which document requests from investors are outstanding, and ensure that newly executed agreements are uploaded promptly. When a lead investor sends a supplemental document request list—a standard step in due diligence—the VA can route each request to the relevant team member and track completion.
Biomarker Data Management: Making the Science Investor-Readable
A biotech's preclinical and translational data package is the scientific foundation of its investor narrative. For platform companies, this package may include biomarker data across multiple indications, target engagement data, pharmacodynamic readouts, and patient-derived xenograft or organoid models. The challenge is not just having the data—it's presenting it in a format that non-specialist investors and their scientific advisors can efficiently evaluate.
A VA can support the scientific team in organizing biomarker data files into structured archives, maintaining a master data inventory that tracks experiment IDs, assay types, and document versions, and formatting summary tables and figure legends for inclusion in the investor presentation and data room. While interpretation of the science remains the scientists' domain, the logistical work of organizing, versioning, and presenting data can be substantially delegated.
CRO Vendor Contract Coordination: Where the Clinical Program Actually Begins
As a biotech company prepares to enter clinical development, it typically engages three to six CRO and clinical supply vendors simultaneously—a full-service CRO for trial management, a central laboratory, a clinical pharmacology unit, a contract manufacturing organization (CMO), and a comparator drug supplier. Each engagement generates a Request for Proposal, a budget negotiation cycle, a Master Service Agreement, and a Work Order—resulting in 20 to 30 contracts requiring review, redline tracking, and execution before first patient first visit.
A VA can manage the entire vendor contract lifecycle: maintaining a contract tracker with each vendor's proposal status, coordinating scheduling of negotiation calls, routing draft agreements to legal and finance for review, tracking redline versions, and managing execution workflows through DocuSign or equivalent platforms. This keeps the CRO contracting process organized and on schedule without pulling the CFO or legal counsel into daily administrative follow-up.
Lean biotech teams ready to build this operational support layer can find experienced VAs at Stealth Agents.
Sources
- Biotechnology Innovation Organization (BIO). Biotech Investment and Financing Report, 2024. bio.org
- NVCA / PitchBook. Venture Monitor Q4 2024. nvca.org
- Datasite. M&A and Capital Raise Data Room Best Practices. datasite.com